Immunologic abnormalities in angioimmunoblastic lymphadenopathy
- PMID: 2822218
- DOI: 10.1002/1097-0142(19871115)60:10<2412::aid-cncr2820601010>3.0.co;2-f
Immunologic abnormalities in angioimmunoblastic lymphadenopathy
Abstract
In this study we describe the results of phenotypic, serologic, and functional analyses performed in nine patients with angioimmunoblastic lymphadenopathy (AILD). The study investigates the nature of the T-cell defects which seem to represent a consistent feature in this disease. The study, based on the analysis of T-cell subsets with monoclonal antibodies and on functional in vitro tests, showed the following main abnormalities: reduction of the absolute number of circulating T-cells; inversion of the CD4/CD8 ratio, both in the peripheral blood and in the involved lymph nodes; high percentages of activated T-cells (CD8+/HLA-DR+); defective T-cell response in vitro to the PHA mitogen; and minimal helper and enhanced in vitro suppressor functions. Some of these immunologic dysfunctions are also observed in acquired immune deficiency syndrome (AIDS) which has in common with AILD several clinical features. However, no evidence of HTLV-III infection could be demonstrated in our patients with AILD.
Similar articles
-
Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.Am J Med. 1986 Mar;80(3):345-50. doi: 10.1016/0002-9343(86)90704-7. Am J Med. 1986. PMID: 3006485
-
A study of lymphocyte subsets in patients with angioimmunoblastic lymphadenopathy.Br J Haematol. 1986 Apr;62(4):615-8. doi: 10.1111/j.1365-2141.1986.tb04083.x. Br J Haematol. 1986. PMID: 3485992
-
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).J Immunol. 1986 Oct 15;137(8):2514-21. J Immunol. 1986. PMID: 3489767
-
Immunopathogenesis of the acquired immunodeficiency syndrome.Ann Intern Med. 1985 Nov;103(5):704-9. doi: 10.7326/0003-4819-103-5-704. Ann Intern Med. 1985. PMID: 2996403 Review.
-
Angioimmunoblastic lymphadenopathy with dysproteinemia: report of a case in infancy with review of literature.Pediatr Hematol Oncol. 1989;6(1):37-44. doi: 10.3109/08880018909014579. Pediatr Hematol Oncol. 1989. PMID: 2701700 Review.
Cited by
-
Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.J Exp Med. 2001 Oct 1;194(7):927-40. doi: 10.1084/jem.194.7.927. J Exp Med. 2001. PMID: 11581315 Free PMC article.
-
T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.Am J Clin Pathol. 2017 Feb 1;147(2):188-203. doi: 10.1093/ajcp/aqw213. Am J Clin Pathol. 2017. PMID: 28395105 Free PMC article.
-
Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.Pathol Oncol Res. 2012 Jul;18(3):737-41. doi: 10.1007/s12253-011-9475-7. Epub 2011 Nov 30. Pathol Oncol Res. 2012. PMID: 22127590 No abstract available.
-
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.Int J Hematol. 2008 Nov;88(4):434-440. doi: 10.1007/s12185-008-0176-2. Epub 2008 Oct 7. Int J Hematol. 2008. PMID: 18839273
-
Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.Int J Clin Exp Med. 2015 Sep 15;8(9):14656-71. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26628948 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials